verified COP 9,6 · D1 • database Scopus / SJR & Web of Science & DOAJ indexed

United Kingdom · BMJ Publishing Group

workspace_premium D1 Top 10% — Immunology and Allergy verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Journal for ImmunoTherapy of Cancer

Journal for ImmunoTherapy of Cancer is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 136. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1694 €. The scope of the journal is focused on tumour immunology, cancer immunotherapy, immunotherapy biomarkers. It has a COP Index of 9,6 (best band D1). It is published in English. It has a COP Index of 9,6.

Journal for ImmunoTherapy of Cancer focuses its scope in these topics and keywords: immunotherapy, response, cancer, tumor, t, society, patient, therapy, cell, carcinoma, ...

Publisher: BMJ Publishing Group

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

COP Index trending_up

9,6 D1 Top 10%

9 of 185 journals in Immunology and Allergy

H-index · SJR 136 · 4,22

Acceptance rate pie_chart

26% Selective

Source Acceptance_Rate

Time to publication hourglass_top

8 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

1.694 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

COP Index

9,6

D1 Top 10%

SJR Impact

4,22

H-index

136

Docs (year)

471

Docs 3y

1524

Total refs

20875

Cites 3y

14439

Citable 3y

1494

Cites/Doc 2y

9.1

Ref/Doc

44.32

Immediate OA

1694 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review